Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Abstract Background Gingivobuccal complex oral squamous cell carcinoma (GBC-OSCC) is an aggressive malignancy with high mortality often preceded by premalignant lesions, including leukoplakia. Previous studies have reported genomic drivers in OSCC, but much remains to be elucidated about DNA methyla...

Full description

Bibliographic Details
Main Authors: Mayuri Inchanalkar, Sumana Srivatsa, Srikant Ambatipudi, Priyanka G. Bhosale, Asawari Patil, Alejandro A. Schäffer, Niko Beerenwinkel, Manoj B. Mahimkar
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Clinical Epigenetics
Subjects:
Online Access:https://doi.org/10.1186/s13148-023-01510-z
_version_ 1797817914610417664
author Mayuri Inchanalkar
Sumana Srivatsa
Srikant Ambatipudi
Priyanka G. Bhosale
Asawari Patil
Alejandro A. Schäffer
Niko Beerenwinkel
Manoj B. Mahimkar
author_facet Mayuri Inchanalkar
Sumana Srivatsa
Srikant Ambatipudi
Priyanka G. Bhosale
Asawari Patil
Alejandro A. Schäffer
Niko Beerenwinkel
Manoj B. Mahimkar
author_sort Mayuri Inchanalkar
collection DOAJ
description Abstract Background Gingivobuccal complex oral squamous cell carcinoma (GBC-OSCC) is an aggressive malignancy with high mortality often preceded by premalignant lesions, including leukoplakia. Previous studies have reported genomic drivers in OSCC, but much remains to be elucidated about DNA methylation patterns across different stages of oral carcinogenesis. Results There is a serious lack of biomarkers and clinical application of biomarkers for early detection and prognosis of gingivobuccal complex cancers. Hence, in search of novel biomarkers, we measured genome-wide DNA methylation in 22 normal oral tissues, 22 leukoplakia, and 74 GBC-OSCC tissue samples. Both leukoplakia and GBC-OSCC had distinct methylation profiles as compared to normal oral tissue samples. Aberrant DNA methylation increases during the different stages of oral carcinogenesis, from premalignant lesions to carcinoma. We identified 846 and 5111 differentially methylated promoters in leukoplakia and GBC-OSCC, respectively, with a sizable fraction shared between the two sets. Further, we identified potential biomarkers from integrative analysis in gingivobuccal complex cancers and validated them in an independent cohort. Integration of genome, epigenome, and transcriptome data revealed candidate genes with gene expression synergistically regulated by copy number and DNA methylation changes. Regularised Cox regression identified 32 genes associated with patient survival. In an independent set of samples, we validated eight genes (FAT1, GLDC, HOXB13, CST7, CYB5A, MLLT11, GHR, LY75) from the integrative analysis and 30 genes from previously published reports. Bisulfite pyrosequencing validated GLDC (P = 0.036), HOXB13 (P < 0.0001) promoter hypermethylation, and FAT1 (P < 0.0001) hypomethylation in GBC-OSCC compared to normal controls. Conclusions Our findings identified methylation signatures associated with leukoplakia and gingivobuccal complex cancers. The integrative analysis in GBC-OSCC identified putative biomarkers that enhance existing knowledge of oral carcinogenesis and may potentially help in risk stratification and prognosis of GBC-OSCC. Graphical abstract
first_indexed 2024-03-13T09:00:30Z
format Article
id doaj.art-68e3d9c0391a4ad49e33391560a83b9e
institution Directory Open Access Journal
issn 1868-7083
language English
last_indexed 2024-03-13T09:00:30Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Clinical Epigenetics
spelling doaj.art-68e3d9c0391a4ad49e33391560a83b9e2023-05-28T11:20:09ZengBMCClinical Epigenetics1868-70832023-05-0115111610.1186/s13148-023-01510-zGenome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancersMayuri Inchanalkar0Sumana Srivatsa1Srikant Ambatipudi2Priyanka G. Bhosale3Asawari Patil4Alejandro A. Schäffer5Niko Beerenwinkel6Manoj B. Mahimkar7Mahimkar Lab, Cancer Research Institute (CRI), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CenterDepartment of Biosystems Science and Engineering, ETH ZurichMahimkar Lab, Cancer Research Institute (CRI), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CenterMahimkar Lab, Cancer Research Institute (CRI), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CenterHomi Bhabha National InstituteCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, and National Center for Biotechnology Information, National Institutes of HealthDepartment of Biosystems Science and Engineering, ETH ZurichMahimkar Lab, Cancer Research Institute (CRI), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CenterAbstract Background Gingivobuccal complex oral squamous cell carcinoma (GBC-OSCC) is an aggressive malignancy with high mortality often preceded by premalignant lesions, including leukoplakia. Previous studies have reported genomic drivers in OSCC, but much remains to be elucidated about DNA methylation patterns across different stages of oral carcinogenesis. Results There is a serious lack of biomarkers and clinical application of biomarkers for early detection and prognosis of gingivobuccal complex cancers. Hence, in search of novel biomarkers, we measured genome-wide DNA methylation in 22 normal oral tissues, 22 leukoplakia, and 74 GBC-OSCC tissue samples. Both leukoplakia and GBC-OSCC had distinct methylation profiles as compared to normal oral tissue samples. Aberrant DNA methylation increases during the different stages of oral carcinogenesis, from premalignant lesions to carcinoma. We identified 846 and 5111 differentially methylated promoters in leukoplakia and GBC-OSCC, respectively, with a sizable fraction shared between the two sets. Further, we identified potential biomarkers from integrative analysis in gingivobuccal complex cancers and validated them in an independent cohort. Integration of genome, epigenome, and transcriptome data revealed candidate genes with gene expression synergistically regulated by copy number and DNA methylation changes. Regularised Cox regression identified 32 genes associated with patient survival. In an independent set of samples, we validated eight genes (FAT1, GLDC, HOXB13, CST7, CYB5A, MLLT11, GHR, LY75) from the integrative analysis and 30 genes from previously published reports. Bisulfite pyrosequencing validated GLDC (P = 0.036), HOXB13 (P < 0.0001) promoter hypermethylation, and FAT1 (P < 0.0001) hypomethylation in GBC-OSCC compared to normal controls. Conclusions Our findings identified methylation signatures associated with leukoplakia and gingivobuccal complex cancers. The integrative analysis in GBC-OSCC identified putative biomarkers that enhance existing knowledge of oral carcinogenesis and may potentially help in risk stratification and prognosis of GBC-OSCC. Graphical abstracthttps://doi.org/10.1186/s13148-023-01510-zLeukoplakiaGingivobuccal complex cancersOSCCDNA methylationIntegrative analysisPrognosis
spellingShingle Mayuri Inchanalkar
Sumana Srivatsa
Srikant Ambatipudi
Priyanka G. Bhosale
Asawari Patil
Alejandro A. Schäffer
Niko Beerenwinkel
Manoj B. Mahimkar
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
Clinical Epigenetics
Leukoplakia
Gingivobuccal complex cancers
OSCC
DNA methylation
Integrative analysis
Prognosis
title Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
title_full Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
title_fullStr Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
title_full_unstemmed Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
title_short Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
title_sort genome wide dna methylation profiling of hpv negative leukoplakia and gingivobuccal complex cancers
topic Leukoplakia
Gingivobuccal complex cancers
OSCC
DNA methylation
Integrative analysis
Prognosis
url https://doi.org/10.1186/s13148-023-01510-z
work_keys_str_mv AT mayuriinchanalkar genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT sumanasrivatsa genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT srikantambatipudi genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT priyankagbhosale genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT asawaripatil genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT alejandroaschaffer genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT nikobeerenwinkel genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers
AT manojbmahimkar genomewidednamethylationprofilingofhpvnegativeleukoplakiaandgingivobuccalcomplexcancers